This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Program
Race is progressing a robust pipeline of clinical activities for RC220 bisantrene.
RC220 is a proprietary formulation designed to enable peripheral and central intravenous administration of bisantrene.
